Valacyclovir hydrochloride and Bacitracin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Valacyclovir hydrochloride (valacyclovir hydrochloride) and Bacitracin (bacitracin). Common drug interactions include anxiety among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Valacyclovir hydrochloride and Bacitracin. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Valacyclovir hydrochloride?

Valacyclovir hydrochloride has active ingredients of valacyclovir hydrochloride. It is often used in herpes zoster. eHealthMe is studying from 12,929 Valacyclovir hydrochloride users. Check the latest studies of Valacyclovir hydrochloride.

What is Bacitracin?

Bacitracin has active ingredients of bacitracin. eHealthMe is studying from 1,214 Bacitracin users. Check the latest studies of Bacitracin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

12 people who take Valacyclovir hydrochloride and Bacitracin together, and have interactions are studied.

Valacyclovir hydrochloride and Bacitracin drug interactions.

What are the common drug interactions of Valacyclovir Hydrochloride and Bacitracin, by gender? *:

female:

  1. Anxiety
  2. Blindness transient (sudden loss of vision)
  3. Bone disorder
  4. C-reactive protein increased
  5. Cardiac murmur (an heart sound in valve abnormality)
  6. Diarrhoea
  7. Disability
  8. Febrile neutropenia (fever with reduced white blood cells)
  9. Hypersensitivity
  10. Immobile (not moving)

male:

  1. Anaemia (lack of blood)
  2. Diplopia (double vision)
  3. Vertigo
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Anxiety
  6. Aplasia pure red cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells)
  7. Chronic kidney disease
  8. Emotional distress
  9. Epistaxis (bleed from the nose)
  10. Hypertension (high blood pressure)

What are the common drug interactions of Valacyclovir Hydrochloride and Bacitracin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anaemia (lack of blood)
  2. Aplasia pure red cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells)
  3. Blindness transient (sudden loss of vision)
  4. Bone disorder
  5. Cardiac murmur (an heart sound in valve abnormality)
  6. Disability
  7. Epistaxis (bleed from the nose)
  8. Hypersensitivity
  9. Immobile (not moving)
  10. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)

40-49:

  1. Light chain analysis increased
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Monoclonal immunoglobulin present
  4. Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)
  5. Protein urine present
  6. Transitional cell carcinoma (cancer tumour inner most layer of urinary system)
  7. Upper respiratory tract infection

50-59:

  1. Febrile neutropenia (fever with reduced white blood cells)

60+:

  1. Diplopia (double vision)
  2. Light chain analysis increased
  3. C-reactive protein increased
  4. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  5. Pyrexia (fever)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Monoclonal immunoglobulin present
  8. Muscle spasms (muscle contraction)
  9. Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)
  10. Protein urine present

What are the existing conditions these people have? *

  1. Pain: 3 people, 25.00%
  2. Inflammation: 2 people, 16.67%
  3. Nervousness: 2 people, 16.67%
  4. Infection: 2 people, 16.67%
  5. Respiratory Tract Congestion (blockage on respiratory system): 2 people, 16.67%
  6. Multiple Allergies (allergy to multiple agents): 2 people, 16.67%
  7. Multiple Myeloma (cancer of the plasma cells): 2 people, 16.67%
  8. Constipation: 2 people, 16.67%
  9. Cough: 2 people, 16.67%
  10. Fungal Infection: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Valacyclovir hydrochloride and Bacitracin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Valacyclovir hydrochloride and Bacitracin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Valacyclovir hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bacitracin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valacyclovir hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bacitracin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on valacyclovir hydrochloride and bacitracin (the active ingredients of Valacyclovir hydrochloride and Bacitracin, respectively), and Valacyclovir hydrochloride and Bacitracin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: